Foundry Partners’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-75,450
| Closed | -$3.08M | – | 373 |
|
|
2021
Q1 | $3.08M | Sell |
75,450
-2,930
| -4% | -$120K | 0.1% | 235 |
|
|
2020
Q4 | $3.55M | Buy |
78,380
+2,885
| +4% | +$131K | 0.14% | 203 |
|
|
2020
Q3 | $2.67M | Buy |
75,495
+190
| +0.3% | +$6.73K | 0.13% | 209 |
|
|
2020
Q2 | $2.84M | Buy |
75,305
+11,735
| +18% | +$443K | 0.14% | 197 |
|
|
2020
Q1 | $1.84M | Buy |
63,570
+38,680
| +155% | +$1.12M | 0.1% | 229 |
|
|
2019
Q4 | $1.29M | Sell |
24,890
-14,725
| -37% | -$764K | 0.05% | 304 |
|
|
2019
Q3 | $2.17M | Sell |
39,615
-15,300
| -28% | -$840K | 0.09% | 251 |
|
|
2019
Q2 | $2.23M | Sell |
54,915
-475
| -0.9% | -$19.3K | 0.09% | 249 |
|
|
2019
Q1 | $1.68M | Buy |
55,390
+50
| +0.1% | +$1.51K | 0.07% | 286 |
|
|
2018
Q4 | $1.86M | Sell |
55,340
-1,075
| -2% | -$36.1K | 0.08% | 274 |
|
|
2018
Q3 | $2.38M | Buy |
+56,415
| New | +$2.38M | 0.09% | 268 |
|